Global Eosinophilic Esophagitis Drug Market Status and Outlook 2018-2025

August 2018 | 134 pages | ID: G70FBF8877FEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• AstraZeneca
• GSK
• Bayer
• Adare Pharmaceuticals
• DBV Technologies
• Dr. Falk Pharma
• Quorum Innovations
• Shire
• Calypso
• Celgene
• Regeneron

Market by Type

• Budesonide
• Fluticasone
• Others

Market by Application

• Hospitals
• Clinics
• Drugstore

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Eosinophilic Esophagitis Drug Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Budesonide
  3.1.2 Fluticasone
  3.1.3 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospitals
  4.1.2 Clinics
  4.1.3 Drugstore
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Budesonide Production by Region
    6.1.1.2 Fluticasone Production by Region
    6.1.1.3 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospitals Production by Region
    6.1.2.2 Clinics Production by Region
    6.1.2.3 Drugstore Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Budesonide Demand by Region
    6.2.1.2 Fluticasone Demand by Region
    6.2.1.3 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospitals Demand by Region
    6.2.2.2 Clinics Demand by Region
    6.2.2.3 Drugstore Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 AstraZeneca
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 GSK
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Bayer
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Adare Pharmaceuticals
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 DBV Technologies
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Dr. Falk Pharma
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Quorum Innovations
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Shire
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Calypso
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Celgene
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Regeneron

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Eosinophilic Esophagitis Drug Industry Dynamics & Regulations List
Table Global Eosinophilic Esophagitis Drug Sales Revenue, Cost and Margin, 2015-2018E
Table Global Eosinophilic Esophagitis Drug Market Status by Type 2015-2018E, in USD Million
Table Global Eosinophilic Esophagitis Drug Market Status by Application 2015-2018E, in USD Million
Table Global Eosinophilic Esophagitis Drug Market Status by Application 2015-2018E, in Volume
Table Global Eosinophilic Esophagitis Drug Market by Region 2015-2018E, in USD Million
Table Global Eosinophilic Esophagitis Drug Market Share by Region in 2018, in USD Million
Table Global Eosinophilic Esophagitis Drug Market by Region 2015-2018E, in Volume
Table Global Eosinophilic Esophagitis Drug Market Share by Region in 2018, in Volume
Table Budesonide Production Value by Region 2015-2018E, in USD Million
Table Budesonide Production Volume by Region 2015-2018E, in Volume
Table Fluticasone Production Value by Region 2015-2018E, in USD Million
Table Fluticasone Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Hospitals Production Value by Region 2015-2018E, in USD Million
Table Hospitals Production Volume by Region 2015-2018E, in Volume
Table Clinics Production Value by Region 2015-2018E, in USD Million
Table Clinics Production Volume by Region 2015-2018E, in Volume
Table Drugstore Production Value by Region 2015-2018E, in USD Million
Table Drugstore Production Volume by Region 2015-2018E, in Volume
Table Budesonide Market Size by Region 2015-2018E, in USD Million
Table Budesonide Market Size by Region 2015-2018E, in Volume
Table Fluticasone Market Size by Region 2015-2018E, in USD Million
Table Fluticasone Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Hospitals Market Size by Region 2015-2018E, in USD Million
Table Hospitals Market Size by Region 2015-2018E, in Volume
Table Clinics Market Size by Region 2015-2018E, in USD Million
Table Clinics Market Size by Region 2015-2018E, in Volume
Table Drugstore Market Size by Region 2015-2018E, in USD Million
Table Drugstore Market Size by Region 2015-2018E, in Volume
Table GlobalEosinophilic Esophagitis Drug Forecast by Type 2019F-2025F, in USD Million
Table Eosinophilic Esophagitis Drug Forecast by Type 2019F-2025F, in Volume
Table Eosinophilic Esophagitis Drug Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Eosinophilic Esophagitis Drug Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Eosinophilic Esophagitis Drug Market Forecast by Region 2019F-2025F, in USD Million
Table Eosinophilic Esophagitis Drug Market Forecast by Region 2019F-2025F, in Volume
Table AstraZeneca Information
Table Eosinophilic Esophagitis Drug Sales, Cost, Margin of AstraZeneca
Table GSK Information
Table Eosinophilic Esophagitis Drug Sales, Cost, Margin of GSK
Table Bayer Information
Table Eosinophilic Esophagitis Drug Sales, Cost, Margin of Bayer
Table Adare Pharmaceuticals Information
Table Eosinophilic Esophagitis Drug Sales, Cost, Margin of Adare Pharmaceuticals
Table DBV Technologies Information
Table Eosinophilic Esophagitis Drug Sales, Cost, Margin of DBV Technologies
Table Dr. Falk Pharma Information
Table Eosinophilic Esophagitis Drug Sales, Cost, Margin of Dr. Falk Pharma
Table Quorum Innovations Information
Table Eosinophilic Esophagitis Drug Sales, Cost, Margin of Quorum Innovations
Table Shire Information
Table Eosinophilic Esophagitis Drug Sales, Cost, Margin of Shire
Table Calypso Information
Table Eosinophilic Esophagitis Drug Sales, Cost, Margin of Calypso
Table Celgene Information
Table Eosinophilic Esophagitis Drug Sales, Cost, Margin of Celgene
Table Regeneron Information
Table Eosinophilic Esophagitis Drug Sales, Cost, Margin of Regeneron
Table Global Eosinophilic Esophagitis Drug Sales Revenue by Company 2015-2017, in USD Million
Table Global Eosinophilic Esophagitis Drug Sales Volume by Company 2015-2017, in Volume
Table Global Eosinophilic Esophagitis Drug Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Eosinophilic Esophagitis Drug Picture
Figure Eosinophilic Esophagitis Drug Industry Chain Diagram
Figure Global Eosinophilic Esophagitis Drug Sales Revenue 2015-2018E, in USD Million
Figure Global Eosinophilic Esophagitis Drug Sales Volume 2015-2018E, in Volume
Figure Global Eosinophilic Esophagitis Drug Market Status by Type 2015-2018E, in Volume
Figure North America Eosinophilic Esophagitis Drug Market Size and Growth 2015-2018E, in USD Million
Figure North America Eosinophilic Esophagitis Drug Market Size and Growth 2015-2018E, in Volume
Figure Europe Eosinophilic Esophagitis Drug Market Size and Growth 2015-2018E, in USD Million
Figure Europe Eosinophilic Esophagitis Drug Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Eosinophilic Esophagitis Drug Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Eosinophilic Esophagitis Drug Market Size and Growth 2015-2018E, in Volume
Figure South America Eosinophilic Esophagitis Drug Market Size and Growth 2015-2018E, in USD Million
Figure South America Eosinophilic Esophagitis Drug Market Size and Growth 2015-2018E, in Volume
Figure Middle East Eosinophilic Esophagitis Drug Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Eosinophilic Esophagitis Drug Market Size and Growth 2015-2018E, in Volume
Figure Africa Eosinophilic Esophagitis Drug Market Size and Growth 2015-2018E, in USD Million
Figure Africa Eosinophilic Esophagitis Drug Market Size and Growth 2015-2018E, in Volume
Figure Global Eosinophilic Esophagitis Drug Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Eosinophilic Esophagitis Drug Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Eosinophilic Esophagitis Drug Sales Price Forecast 2019F-2025F
Figure Global Eosinophilic Esophagitis Drug Gross Margin Forecast 2019F-2025F
Figure Global Eosinophilic Esophagitis Drug Sales Revenue by Company in 2018, in USD Million
Figure Global Eosinophilic Esophagitis Drug Price by Company in 2018
Figure Global Eosinophilic Esophagitis Drug Gross Margin by Company in 2018